Antifungal activity of thiadiazole derivative in experimental candidiasis in mice
Introduction. In the modern world, more attention is paid to the problem of increasing cases of mycosis. In October 2022, the World Health Organization (WHO) published the first fungal priority pathogens list which constitute the greatest danger to human health. Among mycotic infections, one of the...
Saved in:
| Main Authors: | D. Yu. Ivkin, A. V. Karavaeva, T. F. Chernykh, M. V. Krasnova |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
LLC Center of Pharmaceutical Analytics (LLC «CPHA»)
2024-11-01
|
| Series: | Разработка и регистрация лекарственных средств |
| Subjects: | |
| Online Access: | https://www.pharmjournal.ru/jour/article/view/1981 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Species Distribution, Characterization, and Antifungal Susceptibility Patterns of <i>Candida</i> Isolates Causing Oral and Vulvovaginal Candidiasis in Chile
by: Francisca Nahuelcura, et al.
Published: (2025-07-01) -
Invasive Candidiasis Coinfection in Patients with Severe COVID-19 Disease: Scoping Review
by: Omar Esteban Valencia-Ledezma, et al.
Published: (2025-05-01) -
Invasive Candidiasis in the Intensive Care Unit: Where Are We Now?
by: Jose A. Vazquez, et al.
Published: (2025-03-01) -
Anti-candida activity of Lacticaseibacillus rhamnosus R-2002 and its possible application in candidiasis prevention
by: Aleksanyan Tigran, et al.
Published: (2025-06-01) -
Antifungal Activity of Natural Products and their Derivatives Using an Animal Model of Oral Candidiasis: A Systematic Review
by: Raimundo Euzébio da Costa Neto, et al.
Published: (2025-05-01)